SCHEMBL1242810

SCHEMBL1242810

CCC(NC(=O)c1cn(C2CCN(C(C)=O)C2)c2cc(NC3CCCCC3)c(F)cc2c1=O)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
GAA P10253 2/20 0.51
KDM4E B2RXH2 5/20 0.45
ALDH1A1 P00352 4/20 0.45
LMNA P02545 3/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
MAPT P10636 1/20 0.39
FOXO1 Q12778 1/20 0.37
CYP1A2 P05177 1/20 0.35
TOP2A P11388 1/20 0.35
CYP2C9 P11712 1/20 0.35
TOP2B Q02880 1/20 0.35
CREBBP Q92793 1/20 0.34
PIK3CD O00329 3/20 0.34
PIK3R1 P27986 3/20 0.34
PIK3CA P42336 3/20 0.34
PIK3CG P48736 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1242761 0.91 MEN1 (0.52) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1242841 0.90 MEN1 (0.58) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1243443 0.88 MEN1 (0.49) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1243254 0.86 GAA (0.47) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL4099016 0.86 MEN1 (0.51) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1243435 0.84 MEN1 (0.52) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL27635273 0.83 GAA (0.53) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL27635272 0.82 MEN1 (0.50) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1243864 0.82 MEN1 (0.53) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL27656155 0.82 MEN1 (0.53) MEN1KMT2AGAAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7879878-B2 such as {2-[({[7-(cyclohexylamino)-6-fluoro-4-oxo-1-[(3S)-tetrahydrofuran-3-yl]-1,4-dihydroquinolin-3-yl}carbonyl)amino]ethyl}phosphonic acid, used as platelet aggregation inhibitor and purinergic receptor (P2Y12) inhibitors; therapy for circulatory diseases involving thrombosis via platelet aggregation ASTELLAS PHARMA INC. (JP) 2011-02-01 US disclosed